NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our phosphoramidate chemistry technology to transform some of the most widely prescribed chemotherapy agents into more effective and safer medicines.
While these conventional agents remain part of the standard of care for the treatment of many solid tumours, their efficacy is limited by cancer cell resistance mechanisms and they are often poorly tolerated. Utilising our proprietary ProTide technology, we are developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells.
While these conventional agents remain part of the standard of care for the treatment of many solid tumours, their efficacy is limited by cancer cell resistance mechanisms and they are often poorly tolerated. Utilising our proprietary ProTide technology, we are developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells.
Location: United Kingdom, Scotland, City of Edinburgh
Employees: 11-50
Total raised: $57M
Founded date: 2008
Investors 3
| Date | Name | Website |
| - | Sofinnova ... | sofinnovap... |
| - | Sofinnova ... | sofinnova.... |
| 22.09.2020 | Abingworth... | abingworth... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.04.2014 | Series B | $57M | - |
Mentions in press and media 5
| Date | Title | Description |
| 24.05.2021 | NUCANA PLC NuCana : Notice of AGM - 2020 | NuCana plc Notice of Annual General Meeting Thursday 25 June 2020 at 11.00am Venue Lochside House, 3 Lochside Way, Edinburgh, EH12 9DT, UK NOTICE OF 2020 ANNUAL GENERAL MEETING NuCana plc 77-78 Cannon Street, London, England, EC4N 6AF Compa... |
| 24.05.2021 | NUCANA PLC NuCana : Notice of AGM - 2021 | NuCana plc Notice of Annual General Meeting Thursday 24 June 2021 at 11.00am Venue Lochside House, 3 Lochside Way, Edinburgh, EH12 9DT, UK NOTICE OF 2021 ANNUAL GENERAL MEETING NuCana plc 77-78 Cannon Street, London, England, EC4N 6AF Compa... |
| 13.09.2020 | Акции, стартапы, недвижимость: куда инвестируют Гарвард, Йель, Стэнфорд и другие зарубежные университеты Статьи редакции... | Активы шести университетских фондов — около $178 млрд. Среди их инвестиций компании вроде Google, Facebook и LinkedIn. 13 13 комментариев 8212 просмотров Фонд Гарварда — $40,9 млрд Справка Университет основан в 1636 году, он назван в честь ... |
| 11.04.2014 | NuCana Completes $57M Series B Financing | NuCana, an Edinburgh, UK-based clinical stage biopharmaceutical company, completed a $57m Series B financing. The round was led by new investor Sofinnova Ventures, with participation from Sofinnova Partners, and existing investors Morningsi... |
| 29.11.2011 | NuCana BioMed Closes £6.74M Series A Venture Funding | NuCana BioMed, an Edinburgh UK-based biopharmaceutical company focused on anti-cancer therapies, has closed a £6.74m (approximately $10.4m) Series A venture funding. The round was led by Sofinnova Partners, with participation from Morningsi... |